|
HEATR3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.248590E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.679700E-03 |
| Normal-vs-Stage2 |
9.040600E-01 |
| Normal-vs-Stage3 |
7.306000E-01 |
| Normal-vs-Stage4 |
1.596590E-01 |
| Stage1-vs-Stage2 |
1.619800E-01 |
| Stage1-vs-Stage3 |
7.123700E-02 |
| Stage1-vs-Stage4 |
7.323600E-01 |
| Stage2-vs-Stage3 |
8.761600E-01 |
| Stage2-vs-Stage4 |
2.510400E-01 |
| Stage3-vs-Stage4 |
2.216400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.108180E-01 |
| Normal-vs-AfricanAmerican |
1.398190E-01 |
| Normal-vs-Asian |
5.319000E-01 |
| Caucasian-vs-AfricanAmerican |
6.665200E-01 |
| Caucasian-vs-Asian |
4.059600E-01 |
| AfricanAmerican-vs-Asian |
3.711600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.380200E-02 |
| Normal-vs-Female |
8.055600E-01 |
| Male-vs-Female |
5.426200E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.575300E-03 |
| Normal-vs-Extreme_Weight |
5.884300E-03 |
| Normal-vs-Obese |
7.466000E-01 |
| Normal-vs-Extreme_Obese |
2.556400E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.630400E-01 |
| Normal_Weight-vs-Obese |
4.095800E-02 |
| Normal_Weight-vs-Extreme_Obese |
8.495400E-01 |
| Extreme_Weight-vs-Obese |
7.344400E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.398000E-01 |
| Obese-vs-Extreme_Obese |
3.217200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.771800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.190200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.022430E-01 |
| Normal-vs-Age(81-100Yrs) |
1.691750E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.825600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.669000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.998200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.041200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.056400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.016600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.522000E-02 |
| Normal-VS-Type2 PRCC |
5.170200E-01 |
| Normal-VS-KIRP CIMP |
6.199000E-01 |
| Normal-VS-Unclassified PRCC |
4.704000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.464200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.287600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.623700E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.065000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.922400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.278600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.558810E-01 |
| Normal-vs-N1 |
4.259200E-01 |
| Normal-vs-N2 |
1.257810E-01 |
| N0-vs-N1 |
1.132030E-01 |
| N0-vs-N2 |
1.563770E-01 |
| N1-vs-N2 |
2.660400E-02 |
|
|
